GX INMONIT
LIVE

Serial Number

79455367

Owner

Sensile Medical AG

Filing Date

Feb 25, 2026

Add to watchlist:

No watchlists yet
View on USPTO

GX INMONIT Trademark

Serial Number: 79455367

GX INMONIT is a trademark filed by Sensile Medical AG on February 25, 2026. The trademark is classified under Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). The application is currently pending registration.

Owner Contact Info

Sensile Medical AG (6 trademarks)

Fabrikstrasse 10

Entity Type: 99

Trademark Details

Filing Date

February 25, 2026

Registration Date

Not Registered

Goods & Services

Medical apparatus and instruments; Medical devices; medical devices for storage, preparation and/or administration of a medical substance; drug delivery devices, in particular auto-injectors, pen injectors, syringes, vials, containers; medical devices incorporating software and sensors for monitoring drug delivery, in particular smart add-on monitoring modules for drug delivery devices, smart closure systems and smart caps; medical devices featuring artificial intelligence; electronic and/or internet-enabled medical devices for transmitting drug delivery data to servers, cloud-based systems and/or electronic end devices.

Computer software; downloadable and recorded computer software used to measure, store, collect, transmit, monitor and analyze data from drug delivery devices; software enabling automated and interactive messaging, including chatbot-based communication via third-party messaging platforms; software for integration with messaging services to enable natural language communication with patients without requiring application downloads; software for monitoring patient compliance, medication adherence, and device performance in connection with drug delivery devices; data processing programs; artificial intelligence software for healthcare; computer software for use as an application programming interface (API); wireless transmitters and receivers used with the foregoing; sensors.

Filing History

SN ASSIGNED FOR SECT 66A APPL FROM IB
Jul 30, 2026 REPR